ok, maybe i take some of this back.
It appears that CVAC2018, and CVAC 1012 have actually progressed.
This means that the overall median PFS is true.
We have to wait and see how the final PFS score is generated
sorry for the mistake above.
- Forums
- ASX - By Stock
- IMM
- interim data from can-003 clinical trial
IMM
immutep limited
Add to My Watchlist
2.00%
!
24.5¢

interim data from can-003 clinical trial, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $357.7M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 24.0¢ | $419.2K | 1.737M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 301706 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 28117 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 192523 | 0.240 |
5 | 298882 | 0.235 |
10 | 327911 | 0.230 |
13 | 511200 | 0.225 |
17 | 1170248 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 8320 | 1 |
0.250 | 161392 | 6 |
0.255 | 106804 | 5 |
0.260 | 253203 | 7 |
0.265 | 486184 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online